時間 | 主題 | |||
---|---|---|---|---|
08:00 ~ 08:10 |
Welcome Address
講者:
張心湜, 邱文祥, 歐宴泉, 馮思中, 童敏哲 |
張心湜, 邱文祥, 歐宴泉, 馮思中, 童敏哲 |
||
Robotic Renal Surgery:The Journey over 3,000 procedures
講者:
Prof. Ketan K Badani
座長:
盧星華, 林嘉祥 |
Prof. Ketan K Badani |
盧星華, 林嘉祥 |
||
Outcomes of Robot-assisted Radical Prostatectomy with the Hugo RAS Surgical System: Initial Experience at a High-volume Robotic Center
講者:
Prof. Alexandre Mottrie
座長:
阮雍順, 翁瑋駿 |
Prof. Alexandre Mottrie |
阮雍順, 翁瑋駿 |
||
Telesurgery: A humanitarian pathway to the democratization of access to surgery and surgical education
講者:
Prof. Vipul R. Patel
座長:
謝明里, 吳俊德 |
Prof. Vipul R. Patel |
謝明里, 吳俊德 |
||
Radioligand therapy in prostate cancer and how it changes urological care
講者:
Dr. Renu Eapen
座長:
吳文正, 陳煜 |
Dr. Renu Eapen |
吳文正, 陳煜 |
||
09:30 ~ 09:40 |
Panel Discussion
講者:
All
|
All |
||
09:40 ~ 10:10 |
Coffee Break |
|||
RARP with HINOTORI SR
講者:
Prof. Ryoichi Shiroki
座長:
吳錫金, 吳東霖 |
Prof. Ryoichi Shiroki |
吳錫金, 吳東霖 |
||
10:30 ~ 10:50 |
Is Prostate Cancer Heritable – Lessons Learned and Path Forward
講者:
Prof. Jun Luo
座長:
余家政, 陳冠州 |
Prof. Jun Luo |
余家政, 陳冠州 |
|
Organ Function Sparing in Uro-oncological Surgery
講者:
Prof. Gang Zhu
座長:
蔡曜州, 林仁泰 |
Prof. Gang Zhu |
蔡曜州, 林仁泰 |
||
Digital Healthcare 2024 Age of Generative AI
講者:
Dr. Koon-Ho Rha
座長:
郭振華, 林文榮 |
Dr. Koon-Ho Rha |
郭振華, 林文榮 |
||
11:30 ~ 11:45 |
Panel Discussion
講者:
All
|
All |
||
11:45 ~ 12:00 |
Closing Remark |
|||
14:00 ~ 14:10 |
Opening and Welcome
講者:
歐宴泉, 馮思中, 童敏哲 |
歐宴泉, 馮思中, 童敏哲 |
||
A comparison of patients with mCSPC initiated on enzalutamide or apalutamide
講者:
林奇柏
座長:
邱逸淳, 石宏仁 |
林奇柏 |
邱逸淳, 石宏仁 |
||
Benign Prostatic Enlargement Increases the Risk of Parkinson’s Disease: A Population-Based Study
講者:
陳建凱
座長:
邱逸淳, 石宏仁 |
陳建凱 |
邱逸淳, 石宏仁 |
||
Enfortumab vedotin real world experience from CSMUH
講者:
何承儒
座長:
陳順郎, 歐建慧 |
何承儒 |
陳順郎, 歐建慧 |
||
Laparoscope pectopexy for POP experience sharing
講者:
楊旻鑫
座長:
陳順郎, 歐建慧 |
楊旻鑫 |
陳順郎, 歐建慧 |
||
Effectiveness of Tibial Nerve Stimulation for the Treatment of OAB in Taiwanese
講者:
李定廉
座長:
鄒頡龍, 蔡德甫 |
李定廉 |
鄒頡龍, 蔡德甫 |
||
Mirabegron is better tolerated than solifenacin in Sjogren’s syndrome patients with overactive bladder symptoms
講者:
曾浩翔
座長:
鄒頡龍, 蔡德甫 |
曾浩翔 |
鄒頡龍, 蔡德甫 |
||
MRI fusion biopsy for prostate cancer detection clinical practice experience
講者:
謝博彥
座長:
李建儀, 許毓昭 |
謝博彥 |
李建儀, 許毓昭 |
||
Impact of kidney sparing surgery in UTUC treatment
講者:
王俞傑
座長:
李建儀, 許毓昭 |
王俞傑 |
李建儀, 許毓昭 |
||
15:30 ~ 16:00 |
Coffee Break |
|||
Real-world interim outcomes of new androgen receptor pathway inhibitors (ARPi) of non-metastatic castration-resistant prostate cancer (nmCRPC) in east Asia
講者:
柯旭承
座長:
劉明岳, 林子平 |
柯旭承 |
劉明岳, 林子平 |
||
Life Expectancy and Lifetime Cost for Synchronous Metastatic Prostate Cancer: Taiwan National Cohort Study in 2008-2019
講者:
劉品均
座長:
江冠忠, 陳建綸 |
劉品均 |
江冠忠, 陳建綸 |
||
Comparative Efficacy of Cytoreductive Radical Prostatectomy Versus Systemic Treatment in Synchronous Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study
講者:
李一宏
座長:
許兆畬
|
李一宏 |
許兆畬 |
||
New Metrics in Cancer Prognosis: A Study of Life Expectancy Impact and Healthcare Costs of Upper Tract Urothelial Carcinoma in Taiwan
講者:
胡蔚祥
座長:
陳彥達, 吳其翔 |
胡蔚祥 |
陳彥達, 吳其翔 |
||
Forecasting Bladder Voiding Function and Uroflowmetric Outcomes Based on Intravesical Prostatic Protrusion, Prostatic Dimensions, and Volume Measurements
講者:
許哲元
座長:
楊緒棣, 朱朗軒 |
許哲元 |
楊緒棣, 朱朗軒 |
||
16:50 ~ 17:00 |
Closing Remark |